Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
47.65
-0.50 (-1.04%)
At close: May 7, 2026

Pet Pharm Biotech Revenue

In the year 2025, Pet Pharm Biotech had annual revenue of 222.03M TWD with 69.88% growth. Pet Pharm Biotech had revenue of 137.77M in the half year ending December 31, 2025.

Revenue
222.03M
Revenue Growth
+69.88%
P/S Ratio
12.30
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.73B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025222.03M91.33M69.88%
Dec 31, 2024130.70M12.83M10.89%
Dec 31, 2023117.87M42.13M55.62%
Dec 31, 202275.74M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition